Le Lézard
Classified in: Health
Subjects: TDS, PET, ANW

The first press conference with cats was held in Colombia


BOGOTÁ, Colombia, April 8, 2024 /PRNewswire/ -- In keeping with its purpose of promoting responsible adoption, Sanofi has held the first press conference with the most tender and furry hosts in the world: cats. Attendees at this event, during which the company unveiled its "Adopt Your Allergies" initiative which aims to encourage the adoption of spayed cats to allow people with allergies to fulfil their dream of having a cat as a pet, had the opportunity to meet around 30 felines.

In the Colombian capital, Sanofi and the Adopta No Compres [Adopt, Don't Buy] Foundation presented their new "House of Adoption of Impossible Loves," a space open to the public, especially for those who want to fulfil their dream of adopting a cat to have the opportunity to meet the future member of their family. The event closed with more than 300 requests for adoptions.

The campaign is based on the concept of empowered self-care and combines Sanofi's social commitment with a positive impact on the lives of people and their pets. The campaign is supported by a series of decisive scientific findings: humans are allergic to the Fel d1 protein, which is produced in the sebaceous glands and skin of felines and transmitted to their fur and dander during grooming. It has been proven that when cats are spayed, the production of this allergen is reduced by 90%.

 

Photo - https://mma.prnewswire.com/media/2379935/DSC07637.jpg
Photo - https://mma.prnewswire.com/media/2379933/DSC07589.jpg
Photo - https://mma.prnewswire.com/media/2379932/DSC07518.jpg


These press releases may also interest you

at 04:32
According to the latest BCC...

at 03:05
In Q1 2024, LEO Pharma delivered a revenue growth of 13% in constant exchange rates (CER). The dermatology portfolio saw accelerated growth in revenue of 16%. The acquisition of TMB-001 to the treatment of congenital ichthyosis added a late-stage...

at 02:22
Hansa Biopharma AB (publ), ("Hansa" or the "Company") (STO: HNSA) today announced that the company's registered share capital and number of shares and votes have increased through the issue of 10,474,740 new ordinary shares on 12 April 2024, whereby...

at 02:20
Vicore Pharma Holding (STO:VICO) Stockholm, May 3 2024- Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), publishes the interim...

2 mai 2024
The report titled "Muscle Stimulator Market by Technique (Burst Mode Alternating Current, Functional Electrical Stimulation, Interferential), Modality (Handheld, Portable, Table Top), Area, Application, End-User - Global Forecast 2024-2030" is now...

2 mai 2024
Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), and NovaScan, Inc., a company that develops breakthrough technology for cancer detection and stratification, announce that they have...



News published on and distributed by: